- EurekAlert!Jul 08 11:44 AM
( Medical University of South Carolina ) A new dental adhesive, which incorporates particles of copper iodide that curtail infections, could extend long-term bond strength when compared to typical adhesives and also reduce secondary caries.
U.S. Department of Energy Releases Second Video in Series on How to Write a Successful DOE SBIR/STTR Phase I Grant ...PR Newswire via Yahoo! FinanceJul 19 05:30 AM
ROCHESTER, N.Y., July 19, 2016 /PRNewswire/ -- The U.S. Department of Energy (DOE) SBIR/STTR Programs has released the second of three videos in its highly anticipated series focused exclusively on writing ...
- Business Wire via Yahoo! FinanceJun 29 05:00 AM
Cyteir Therapeutics, Inc., a leader in the development of novel therapeutics based on the biology of DNA repair, today announced that it has received a $2 million, two-year grant from the National Cancer Institute , part of the National Institutes of Health .
- The Sarasota Herald-TribuneJul 23 06:41 AM
Published: Saturday, July 23, 2016 at 2:00 a.m. Last Modified: Friday, July 22, 2016 at 6:33 p.m. The U.S. Small Business Administration has released online tutorials about a program that grants seed money for research and development to "small, innovative and nimble firms across the nation."
- EurekAlert!Jul 21 01:26 PM
( Indiana University ) Arrhythmotech LLC has received a two-year, $1,472,476 grant from the National Institutes of Health to help researchers determine if nerve activity is associated with a common heart rhythm disorder.
- U.S. Department of EnergyJul 21 11:01 AM
July 21, 2016 FY17 SBIR Phase I Release 1 Topics Announced: Includes Fuel Cell Catalysts and Hydrogen Delivery The U.S. Department of Energy (DOE) has announced the 2017 Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) Phase I Release 1 topics, including two subtopics focused on hydrogen and fuel cell technologies. The fuel cell subtopic includes novel ...
- PharmiWebJun 29 07:12 AM
Cyteir Therapeutics , Inc. Posted on: 29 Jun 16 Cyteir Therapeutics, Inc.
- Business WireJun 29 05:14 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #DNArepair --Cyteir Therapeutics, Inc., today announced that it has received a $2 million, two-year grant from the National Cancer Institute.
- Business Wire via Yahoo! FinanceJul 12 09:45 AM
Adding to its growing portfolio of life sciences companies, the Prince William Science Accelerator is set to welcome yet another resident – Celetrix LLC – a biotechnology company.
LightPath Joins Nanomaterial Innovation Limited as Key Industrial Partner on National Science Foundation Phase II SBIR ...Marketwired via Yahoo! FinanceJun 29 06:00 AM
LightPath Technologies, Inc. , a leading vertically integrated global manufacturer, distributor and integrator of proprietary optical and infrared components and high-level assemblies, today announced ...
- related to STTR